9th May ,2022
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting
OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', SSE:688238.SH), today announced that research on novel manufacturing technologies via its OVersatile™ platform will be presented at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual meeting on May 16-19, 2022 in Washington, D.C.